Brief: Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results

Fresh Tracks Therapeutics

10/05/2023 22:30

May 10 (Reuters) - Fresh Tracks Therapeutics Inc
 FRTX.O :
    * FRESH TRACKS THERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * FRESH TRACKS THERAPEUTICS INC Q1 REVENUE $9000
    * FRESH TRACKS THERAPEUTICS - REPORTED POSITIVE TOPLINE
RESULTS
FROM SAD AND MAD PARTS OF PHASE 1 STUDY OF LEAD DYRK1A INHIBITOR
FRTX-02 IN MARCH 2023
    * FRESH TRACKS THERAPEUTICS INC - ONGOING EVALUATION OF
STRATEGIC
OPTIONS TO FURTHER DEVELOP FRTX-02 AND MAXIMIZE SHAREHOLDER
VALUE
    * FRESH TRACKS THERAPEUTICS - REPORTED CASH AND CASH
EQUIVALENTS
OF $10.8 MILLION AS OF MARCH 31, 2023
    * FRESH TRACKS THERAPEUTICS - EXPECTS CASH AND CASH
EQUIVALENTS AS
OF MARCH 31, 2023 WILL BE SUFFICIENT TO FUND OPERATIONS FOR AT
LEAST NEXT 12 MONTHS
    * FRESH TRACKS THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.14

Source text for Eikon:  ID:nGNXbmVlhX 
Further company coverage:  FRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))